Spero Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $110.5M
Liabilities Breakdown FY2024
Total Liabilities: $64.4M
Asset Breakdown
Total Assets: $110.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.9M | 47.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $57.7M | 52.2% |
Liabilities Breakdown
Total Liabilities: $64.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.3M | 11.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $57.1M | 88.7% |